 Imke Janssen
Concepts (328)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 20 | 2018 | 177 | 3.560 |
Why?
| | Menopause | 13 | 2018 | 99 | 2.710 |
Why?
| | Coronary Artery Disease | 6 | 2018 | 128 | 2.140 |
Why?
| | Adiposity | 9 | 2018 | 47 | 1.930 |
Why?
| | Intra-Abdominal Fat | 8 | 2018 | 44 | 1.840 |
Why?
| | Ethnic Groups | 4 | 2018 | 131 | 1.590 |
Why?
| | Depression | 8 | 2016 | 422 | 1.470 |
Why?
| | Calcinosis | 4 | 2016 | 47 | 1.450 |
Why?
| | Testosterone | 4 | 2015 | 34 | 1.440 |
Why?
| | Coronary Vessels | 5 | 2017 | 43 | 1.240 |
Why?
| | Middle Aged | 54 | 2018 | 9619 | 1.150 |
Why?
| | Obesity, Abdominal | 5 | 2018 | 20 | 1.130 |
Why?
| | Stress, Psychological | 3 | 2016 | 253 | 1.100 |
Why?
| | Female | 59 | 2018 | 15278 | 0.960 |
Why?
| | Obesity | 5 | 2015 | 275 | 0.950 |
Why?
| | European Continental Ancestry Group | 15 | 2017 | 524 | 0.950 |
Why?
| | Cardiovascular Diseases | 11 | 2016 | 300 | 0.890 |
Why?
| | Risk Factors | 25 | 2018 | 2205 | 0.880 |
Why?
| | Discrimination (Psychology) | 2 | 2017 | 26 | 0.860 |
Why?
| | Fibrinogen | 2 | 2016 | 32 | 0.800 |
Why?
| | Adult | 33 | 2018 | 8400 | 0.790 |
Why?
| | Perimenopause | 2 | 2016 | 13 | 0.780 |
Why?
| | Disease Progression | 5 | 2017 | 734 | 0.770 |
Why?
| | Body Mass Index | 11 | 2018 | 364 | 0.770 |
Why?
| | African Americans | 13 | 2017 | 617 | 0.760 |
Why?
| | Humans | 62 | 2018 | 25716 | 0.750 |
Why?
| | Longitudinal Studies | 13 | 2018 | 1148 | 0.750 |
Why?
| | United States | 18 | 2018 | 1991 | 0.740 |
Why?
| | Exercise | 4 | 2018 | 322 | 0.670 |
Why?
| | Pain | 1 | 2017 | 273 | 0.660 |
Why?
| | Atherosclerosis | 4 | 2018 | 38 | 0.650 |
Why?
| | Follow-Up Studies | 15 | 2017 | 1772 | 0.640 |
Why?
| | Self Efficacy | 1 | 2014 | 54 | 0.640 |
Why?
| | Tomography, X-Ray Computed | 11 | 2018 | 790 | 0.620 |
Why?
| | Social Support | 1 | 2014 | 186 | 0.590 |
Why?
| | Coronary Angiography | 4 | 2018 | 85 | 0.570 |
Why?
| | Role | 1 | 2012 | 10 | 0.570 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 195 | 0.560 |
Why?
| | General Surgery | 3 | 2015 | 55 | 0.500 |
Why?
| | Healthcare Disparities | 3 | 2017 | 48 | 0.490 |
Why?
| | Laparoscopy | 4 | 2015 | 169 | 0.490 |
Why?
| | Adipose Tissue | 5 | 2018 | 68 | 0.490 |
Why?
| | Chicago | 7 | 2014 | 780 | 0.470 |
Why?
| | Retrospective Studies | 12 | 2017 | 2585 | 0.470 |
Why?
| | Quality Improvement | 3 | 2014 | 130 | 0.450 |
Why?
| | Vascular Calcification | 2 | 2018 | 9 | 0.430 |
Why?
| | Odds Ratio | 7 | 2016 | 278 | 0.430 |
Why?
| | Cross-Sectional Studies | 9 | 2018 | 764 | 0.420 |
Why?
| | Postoperative Complications | 4 | 2016 | 921 | 0.420 |
Why?
| | Asian Americans | 3 | 2017 | 47 | 0.400 |
Why?
| | Hispanic Americans | 4 | 2017 | 168 | 0.400 |
Why?
| | Absorptiometry, Photon | 4 | 2015 | 78 | 0.390 |
Why?
| | Self Care | 4 | 2013 | 102 | 0.380 |
Why?
| | Aortic Diseases | 2 | 2018 | 6 | 0.380 |
Why?
| | Herniorrhaphy | 3 | 2015 | 35 | 0.380 |
Why?
| | Patient Compliance | 5 | 2013 | 199 | 0.370 |
Why?
| | Colectomy | 2 | 2016 | 33 | 0.360 |
Why?
| | Socioeconomic Factors | 6 | 2017 | 319 | 0.350 |
Why?
| | Cohort Studies | 6 | 2017 | 1548 | 0.350 |
Why?
| | Educational Measurement | 2 | 2015 | 65 | 0.350 |
Why?
| | Follicle Stimulating Hormone | 3 | 2015 | 18 | 0.330 |
Why?
| | Postmenopause | 2 | 2017 | 62 | 0.320 |
Why?
| | Waist Circumference | 5 | 2016 | 30 | 0.320 |
Why?
| | Linear Models | 5 | 2016 | 257 | 0.300 |
Why?
| | Sex Hormone-Binding Globulin | 4 | 2011 | 15 | 0.300 |
Why?
| | Estradiol | 2 | 2015 | 46 | 0.300 |
Why?
| | Community Health Workers | 2 | 2013 | 24 | 0.290 |
Why?
| | Mexican Americans | 2 | 2013 | 27 | 0.290 |
Why?
| | Heart Failure | 3 | 2010 | 177 | 0.290 |
Why?
| | Disease Management | 2 | 2015 | 115 | 0.280 |
Why?
| | Premenopause | 3 | 2017 | 20 | 0.270 |
Why?
| | Sleep | 4 | 2013 | 277 | 0.270 |
Why?
| | Prospective Studies | 8 | 2018 | 1520 | 0.250 |
Why?
| | Age Factors | 4 | 2018 | 794 | 0.250 |
Why?
| | Prevalence | 4 | 2016 | 476 | 0.250 |
Why?
| | Time Factors | 5 | 2018 | 1680 | 0.250 |
Why?
| | Insulin Resistance | 2 | 2011 | 57 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2013 | 181 | 0.240 |
Why?
| | Breast Neoplasms | 2 | 2015 | 393 | 0.240 |
Why?
| | Breast Feeding | 2 | 2011 | 112 | 0.230 |
Why?
| | Aortography | 1 | 2018 | 13 | 0.230 |
Why?
| | Carotid Arteries | 3 | 2014 | 46 | 0.230 |
Why?
| | Carotid Artery Diseases | 1 | 2018 | 35 | 0.220 |
Why?
| | Colonic Neoplasms | 2 | 2016 | 81 | 0.220 |
Why?
| | Snacks | 1 | 2018 | 2 | 0.220 |
Why?
| | Food Preferences | 1 | 2018 | 23 | 0.210 |
Why?
| | Consumer Behavior | 1 | 2018 | 18 | 0.210 |
Why?
| | Aged | 13 | 2016 | 8520 | 0.210 |
Why?
| | Delay Discounting | 1 | 2018 | 23 | 0.210 |
Why?
| | Patient Education as Topic | 2 | 2010 | 181 | 0.210 |
Why?
| | Logistic Models | 6 | 2016 | 451 | 0.210 |
Why?
| | Waist-Height Ratio | 1 | 2016 | 5 | 0.200 |
Why?
| | Beverages | 1 | 2016 | 14 | 0.200 |
Why?
| | Metabolic Diseases | 1 | 2016 | 14 | 0.190 |
Why?
| | Incidence | 2 | 2017 | 691 | 0.190 |
Why?
| | Menstrual Cycle | 2 | 2007 | 33 | 0.190 |
Why?
| | Stress, Physiological | 1 | 2016 | 25 | 0.190 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.190 |
Why?
| | Enterostomy | 1 | 2016 | 6 | 0.190 |
Why?
| | Weight Gain | 2 | 2015 | 59 | 0.190 |
Why?
| | Motivation | 2 | 2014 | 90 | 0.190 |
Why?
| | Dyspareunia | 1 | 2015 | 7 | 0.190 |
Why?
| | Practice (Psychology) | 1 | 2015 | 15 | 0.180 |
Why?
| | Abdominal Fat | 1 | 2015 | 10 | 0.180 |
Why?
| | Residence Characteristics | 1 | 2017 | 193 | 0.180 |
Why?
| | Gastrectomy | 1 | 2015 | 22 | 0.180 |
Why?
| | Sexuality | 1 | 2015 | 19 | 0.180 |
Why?
| | Self Report | 2 | 2014 | 166 | 0.180 |
Why?
| | Circadian Rhythm | 3 | 2010 | 262 | 0.180 |
Why?
| | Perception | 1 | 2016 | 77 | 0.180 |
Why?
| | End Stage Liver Disease | 1 | 2015 | 13 | 0.180 |
Why?
| | Writing | 1 | 2015 | 14 | 0.180 |
Why?
| | Inflammation Mediators | 1 | 2016 | 80 | 0.180 |
Why?
| | Clinical Clerkship | 1 | 2015 | 27 | 0.180 |
Why?
| | Carcinoma | 1 | 2016 | 79 | 0.180 |
Why?
| | Certification | 1 | 2015 | 51 | 0.180 |
Why?
| | Stomach Neoplasms | 1 | 2015 | 37 | 0.170 |
Why?
| | Appendectomy | 1 | 2014 | 10 | 0.170 |
Why?
| | Carcinoma, Lobular | 1 | 2015 | 15 | 0.170 |
Why?
| | Appendicitis | 1 | 2014 | 10 | 0.170 |
Why?
| | Pain Measurement | 1 | 2017 | 406 | 0.170 |
Why?
| | Meals | 1 | 2014 | 11 | 0.170 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 67 | 0.170 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2015 | 35 | 0.170 |
Why?
| | Mass Screening | 1 | 2016 | 166 | 0.170 |
Why?
| | Male | 17 | 2018 | 14922 | 0.170 |
Why?
| | Electrocardiography | 1 | 2016 | 198 | 0.170 |
Why?
| | Hernia, Hiatal | 1 | 2014 | 14 | 0.170 |
Why?
| | Personal Autonomy | 1 | 2014 | 6 | 0.170 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2014 | 10 | 0.170 |
Why?
| | Prejudice | 2 | 2013 | 38 | 0.170 |
Why?
| | Hernia, Ventral | 1 | 2014 | 24 | 0.170 |
Why?
| | Surgical Mesh | 1 | 2014 | 30 | 0.170 |
Why?
| | Aorta | 2 | 2011 | 22 | 0.160 |
Why?
| | Cell Cycle Proteins | 2 | 2004 | 20 | 0.160 |
Why?
| | Referral and Consultation | 1 | 2015 | 84 | 0.160 |
Why?
| | Population Surveillance | 1 | 2014 | 118 | 0.160 |
Why?
| | Myelodysplastic Syndromes | 2 | 2004 | 44 | 0.160 |
Why?
| | Employment | 1 | 2013 | 30 | 0.160 |
Why?
| | Personal Satisfaction | 1 | 2014 | 42 | 0.160 |
Why?
| | Chronic Pain | 1 | 2014 | 72 | 0.160 |
Why?
| | Social Perception | 1 | 2013 | 22 | 0.160 |
Why?
| | Body Image | 1 | 2014 | 36 | 0.160 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 221 | 0.160 |
Why?
| | Comorbidity | 2 | 2015 | 474 | 0.160 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2013 | 52 | 0.150 |
Why?
| | Confidence Intervals | 2 | 2015 | 104 | 0.150 |
Why?
| | Morbidity | 2 | 2014 | 57 | 0.150 |
Why?
| | Internship and Residency | 1 | 2015 | 150 | 0.150 |
Why?
| | Decision Making | 1 | 2015 | 175 | 0.150 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 28 | 0.150 |
Why?
| | Body Fat Distribution | 1 | 2012 | 12 | 0.150 |
Why?
| | Transcription Factors | 2 | 2004 | 165 | 0.150 |
Why?
| | Carotid Intima-Media Thickness | 3 | 2018 | 15 | 0.140 |
Why?
| | DNA-Binding Proteins | 2 | 2004 | 225 | 0.140 |
Why?
| | Pulsatile Flow | 1 | 2011 | 5 | 0.140 |
Why?
| | Blood Pressure | 4 | 2014 | 208 | 0.140 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2011 | 2 | 0.130 |
Why?
| | Health Status Disparities | 1 | 2011 | 48 | 0.130 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2013 | 90 | 0.130 |
Why?
| | Directive Counseling | 1 | 2010 | 10 | 0.130 |
Why?
| | Treatment Outcome | 6 | 2016 | 3215 | 0.130 |
Why?
| | Progesterone Congeners | 1 | 2010 | 1 | 0.130 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2010 | 4 | 0.130 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2010 | 6 | 0.130 |
Why?
| | Estrogen Replacement Therapy | 1 | 2010 | 21 | 0.130 |
Why?
| | Hydrocortisone | 1 | 2010 | 45 | 0.120 |
Why?
| | Estrogens | 1 | 2010 | 35 | 0.120 |
Why?
| | Biological Availability | 1 | 2009 | 24 | 0.120 |
Why?
| | Databases, Factual | 3 | 2016 | 264 | 0.120 |
Why?
| | Subcutaneous Fat | 1 | 2009 | 12 | 0.120 |
Why?
| | Hostility | 1 | 2009 | 19 | 0.120 |
Why?
| | Survival Rate | 3 | 2015 | 394 | 0.120 |
Why?
| | Risk Assessment | 3 | 2018 | 674 | 0.120 |
Why?
| | Prognosis | 4 | 2018 | 845 | 0.120 |
Why?
| | Predictive Value of Tests | 3 | 2018 | 552 | 0.110 |
Why?
| | Health Education | 1 | 2008 | 42 | 0.110 |
Why?
| | Quality of Life | 2 | 2010 | 508 | 0.100 |
Why?
| | Single-Blind Method | 3 | 2013 | 121 | 0.100 |
Why?
| | Blood Glucose | 3 | 2014 | 111 | 0.100 |
Why?
| | Bone Marrow Cells | 2 | 2004 | 68 | 0.100 |
Why?
| | Pregnanediol | 1 | 2007 | 5 | 0.100 |
Why?
| | Estrone | 1 | 2007 | 7 | 0.100 |
Why?
| | Luteinizing Hormone | 1 | 2007 | 8 | 0.100 |
Why?
| | Postural Balance | 1 | 2008 | 103 | 0.100 |
Why?
| | Calcium | 1 | 2012 | 479 | 0.100 |
Why?
| | Aging | 2 | 2015 | 1265 | 0.100 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 377 | 0.100 |
Why?
| | Accidental Falls | 1 | 2008 | 90 | 0.100 |
Why?
| | Research Design | 1 | 2008 | 183 | 0.100 |
Why?
| | Gonadal Steroid Hormones | 1 | 2006 | 11 | 0.100 |
Why?
| | Gonadal Hormones | 1 | 2005 | 3 | 0.090 |
Why?
| | Vertigo | 1 | 2005 | 6 | 0.090 |
Why?
| | Schools | 1 | 2005 | 20 | 0.090 |
Why?
| | Students | 1 | 2005 | 21 | 0.090 |
Why?
| | Illinois | 3 | 2014 | 216 | 0.090 |
Why?
| | Phototherapy | 1 | 2005 | 34 | 0.090 |
Why?
| | Sleep Deprivation | 1 | 2005 | 41 | 0.090 |
Why?
| | Lipoproteins, HDL | 2 | 2014 | 29 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2006 | 297 | 0.090 |
Why?
| | Reference Values | 3 | 2013 | 244 | 0.090 |
Why?
| | Adolescent | 2 | 2014 | 2303 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2003 | 7 | 0.080 |
Why?
| | K562 Cells | 1 | 2003 | 8 | 0.080 |
Why?
| | Histones | 1 | 2003 | 19 | 0.080 |
Why?
| | Telomerase | 1 | 2003 | 11 | 0.080 |
Why?
| | Triglycerides | 2 | 2014 | 46 | 0.080 |
Why?
| | Sex Factors | 2 | 2018 | 439 | 0.080 |
Why?
| | Life Style | 3 | 2011 | 173 | 0.070 |
Why?
| | Length of Stay | 2 | 2014 | 292 | 0.070 |
Why?
| | Apoptosis | 1 | 2003 | 283 | 0.070 |
Why?
| | Neuropsychological Tests | 1 | 2004 | 1138 | 0.060 |
Why?
| | Recurrence | 2 | 2014 | 332 | 0.060 |
Why?
| | Asymptomatic Diseases | 1 | 2018 | 14 | 0.060 |
Why?
| | Pulse Wave Analysis | 1 | 2018 | 2 | 0.060 |
Why?
| | Vascular Stiffness | 1 | 2018 | 6 | 0.060 |
Why?
| | Food Dispensers, Automatic | 1 | 2018 | 2 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2013 | 353 | 0.050 |
Why?
| | Tomography | 1 | 2018 | 11 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 36 | 0.050 |
Why?
| | Interviews as Topic | 2 | 2011 | 128 | 0.050 |
Why?
| | Nutritive Value | 1 | 2018 | 27 | 0.050 |
Why?
| | Smoking | 1 | 2018 | 166 | 0.050 |
Why?
| | Ultrasonography | 1 | 2018 | 177 | 0.050 |
Why?
| | Diet | 1 | 2018 | 171 | 0.050 |
Why?
| | Cognition | 1 | 2004 | 883 | 0.050 |
Why?
| | Pericardium | 1 | 2017 | 24 | 0.050 |
Why?
| | Hospitalization | 2 | 2010 | 262 | 0.050 |
Why?
| | Pilot Projects | 1 | 2018 | 375 | 0.050 |
Why?
| | Asian Continental Ancestry Group | 1 | 2016 | 50 | 0.050 |
Why?
| | Energy Intake | 1 | 2016 | 84 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2013 | 1113 | 0.050 |
Why?
| | Anastomosis, Surgical | 1 | 2016 | 49 | 0.050 |
Why?
| | Climacteric | 1 | 2015 | 10 | 0.050 |
Why?
| | Hot Flashes | 1 | 2015 | 14 | 0.050 |
Why?
| | Hernia, Umbilical | 1 | 2015 | 4 | 0.050 |
Why?
| | Causality | 1 | 2015 | 50 | 0.050 |
Why?
| | Hernia, Inguinal | 1 | 2015 | 22 | 0.040 |
Why?
| | Global Health | 1 | 2015 | 51 | 0.040 |
Why?
| | Intestines | 1 | 2016 | 103 | 0.040 |
Why?
| | Survival Analysis | 1 | 2015 | 360 | 0.040 |
Why?
| | Hypertriglyceridemia | 1 | 2014 | 24 | 0.040 |
Why?
| | Affect | 2 | 2005 | 68 | 0.040 |
Why?
| | Perioperative Care | 1 | 2015 | 68 | 0.040 |
Why?
| | Operative Time | 1 | 2014 | 67 | 0.040 |
Why?
| | S Phase | 2 | 2004 | 12 | 0.040 |
Why?
| | E2F Transcription Factors | 2 | 2004 | 6 | 0.040 |
Why?
| | E2F1 Transcription Factor | 2 | 2004 | 6 | 0.040 |
Why?
| | Retinoblastoma Protein | 2 | 2004 | 9 | 0.040 |
Why?
| | Karyotyping | 2 | 2004 | 12 | 0.040 |
Why?
| | Papanicolaou Test | 1 | 2013 | 11 | 0.040 |
Why?
| | Vaginal Smears | 1 | 2013 | 18 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2014 | 129 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 163 | 0.040 |
Why?
| | Biopsy | 1 | 2015 | 260 | 0.040 |
Why?
| | Mammography | 1 | 2013 | 33 | 0.040 |
Why?
| | Health Status | 1 | 2015 | 235 | 0.040 |
Why?
| | Transcription, Genetic | 2 | 2004 | 121 | 0.040 |
Why?
| | Community Health Services | 1 | 2013 | 28 | 0.040 |
Why?
| | Wound Healing | 1 | 2014 | 160 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2015 | 459 | 0.040 |
Why?
| | Radiography | 1 | 2015 | 687 | 0.040 |
Why?
| | Hypertension | 1 | 2014 | 211 | 0.040 |
Why?
| | Clinical Competence | 1 | 2015 | 237 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 80 | 0.040 |
Why?
| | Polysomnography | 1 | 2013 | 90 | 0.040 |
Why?
| | Actigraphy | 1 | 2013 | 90 | 0.040 |
Why?
| | Health Behavior | 1 | 2013 | 150 | 0.040 |
Why?
| | Overweight | 1 | 2013 | 60 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2003 | 352 | 0.040 |
Why?
| | Waist-Hip Ratio | 1 | 2011 | 14 | 0.030 |
Why?
| | African Continental Ancestry Group | 1 | 2013 | 163 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2011 | 25 | 0.030 |
Why?
| | Elasticity | 1 | 2011 | 55 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2011 | 27 | 0.030 |
Why?
| | Cholesterol, LDL | 1 | 2011 | 41 | 0.030 |
Why?
| | Tunica Intima | 1 | 2011 | 32 | 0.030 |
Why?
| | Body Composition | 1 | 2011 | 62 | 0.030 |
Why?
| | Administration, Cutaneous | 1 | 2010 | 5 | 0.030 |
Why?
| | Androgens | 1 | 2010 | 7 | 0.030 |
Why?
| | Saliva | 1 | 2010 | 59 | 0.030 |
Why?
| | Insulin | 1 | 2011 | 90 | 0.030 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2010 | 17 | 0.030 |
Why?
| | Pregnancy | 1 | 2011 | 364 | 0.030 |
Why?
| | Psychological Tests | 1 | 2009 | 65 | 0.030 |
Why?
| | Physical Fitness | 1 | 2009 | 49 | 0.030 |
Why?
| | Lactation | 1 | 2010 | 66 | 0.030 |
Why?
| | Behavioral Medicine | 1 | 2008 | 8 | 0.030 |
Why?
| | Torque | 1 | 2008 | 30 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2009 | 4342 | 0.030 |
Why?
| | Patient Participation | 1 | 2008 | 41 | 0.030 |
Why?
| | Educational Status | 1 | 2009 | 232 | 0.030 |
Why?
| | Mothers | 1 | 2010 | 123 | 0.030 |
Why?
| | Rotation | 1 | 2008 | 142 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2007 | 22 | 0.030 |
Why?
| | Patient Care Team | 1 | 2008 | 112 | 0.030 |
Why?
| | Aromatase | 1 | 2006 | 3 | 0.020 |
Why?
| | Cytochrome P-450 CYP1B1 | 1 | 2006 | 3 | 0.020 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 6 | 0.020 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 5 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2006 | 10 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2008 | 211 | 0.020 |
Why?
| | Health Surveys | 1 | 2006 | 95 | 0.020 |
Why?
| | Sleep Disorders, Intrinsic | 1 | 2005 | 7 | 0.020 |
Why?
| | Continental Population Groups | 1 | 2006 | 94 | 0.020 |
Why?
| | Appointments and Schedules | 1 | 2005 | 13 | 0.020 |
Why?
| | Semicircular Canals | 1 | 2005 | 3 | 0.020 |
Why?
| | Seasons | 1 | 2005 | 36 | 0.020 |
Why?
| | Medical Records | 1 | 2005 | 37 | 0.020 |
Why?
| | Arousal | 1 | 2005 | 61 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2004 | 68 | 0.020 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2004 | 1 | 0.020 |
Why?
| | Space Perception | 1 | 2004 | 33 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 35 | 0.020 |
Why?
| | Psychomotor Performance | 1 | 2005 | 209 | 0.020 |
Why?
| | Granulocytes | 1 | 2003 | 25 | 0.020 |
Why?
| | DNA Primers | 1 | 2003 | 67 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2003 | 88 | 0.020 |
Why?
| | Bone Marrow | 1 | 2003 | 53 | 0.020 |
Why?
| | Remission Induction | 1 | 2003 | 121 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 212 | 0.020 |
Why?
| | Blotting, Western | 1 | 2003 | 227 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2003 | 203 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 1797 | 0.020 |
Why?
| | Memory | 1 | 2004 | 307 | 0.020 |
Why?
| | Acute Disease | 1 | 2003 | 256 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2003 | 463 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 302 | 0.020 |
Why?
|
|
Janssen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|